Ngā hua rapu kaituhi

1

Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia mā Göllner, Stefanie, Müller-Tidow, Carsten

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

The Indications for Allogeneic Stem Cell Transplantation in Myeloid Malignancies mā Müller, Lutz P, Müller-Tidow, Carsten

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

The limited contribution of DNA methylation to PML-RARα induced leukemia mā Rohde, Christian, Schoofs, Till, Müller-Tidow, Carsten

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

Improving consolidation therapy in acute myeloid leukemia - a tough nut to crack mā Schlenk, Richard F., Jaramillo, Sonia, Müller-Tidow, Carsten

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting mā Wünsch, Christian, Banck, Henrik, Müller-Tidow, Carsten, Dugas, Martin

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML mā BANCK, HENRIK, DUGAS, MARTIN, MÜLLER-TIDOW, CARSTEN, SANDMANN, SARAH

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study mā Dugas, Martin, Lange, Matthias, Berdel, Wolfgang E, Müller-Tidow, Carsten

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

Characterization of the Ca(2+)-regulated Ezrin-S100P Interaction and Its Role in Tumor Cell Migration mā Austermann, Judith, Nazmi, Ali Reza, Müller-Tidow, Carsten, Gerke, Volker

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

The Treatment of Elderly Patients With Acute Myeloid Leukemia mā Krug, Utz, Büchner, Thomas, Berdel, Wolfgang E, Müller-Tidow, Carsten

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

HIS-based Kaplan-Meier plots - a single source approach for documenting and reusing routine survival information mā Breil, Bernhard, Semjonow, Axel, Müller-Tidow, Carsten, Fritz, Fleur, Dugas, Martin

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation mā Korell, Felix, Schreck, Nicholas, Müller-Tidow, Carsten, Dreger, Peter, Luft, Thomas

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
12

Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia mā Wass, Maxi, Hitz, Friederike, Schaffrath, Judith, Müller-Tidow, Carsten, Müller, Lutz P.

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
13

DDX41-related myeloid neoplasia mā Maciejewski, Jaroslaw P., Padgett, Richard A., Brown, Anna L., Müller-Tidow, Carsten

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
14

Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment mā Marra, Alessandro, Richardsen, Gunther, Wagner, Wolfgang, Müller-Tidow, Carsten, Koch, Olaf M., Hillejan, Ludger

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
15

Hematological Malignancies in Adults With a Family Predisposition mā Bochtler, Tilmann, Haag, Georg-Martin, Schott, Sarah, Kloor, Matthias, Krämer, Alwin, Müller-Tidow, Carsten

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
16

Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity mā Schaffrath, Judith, Schmoll, Hans-Joachim, Voigt, Wieland, Müller, Lutz P., Müller-Tidow, Carsten, Mueller, Thomas

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
17

Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants mā Restle, Anja, Färber, Martin, Baumann, Cindy, Böhringer, Michael, Scheidtmann, Karl Heinz, Müller-Tidow, Carsten, Wiesmüller, Lisa

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
18

The Inhibitor of Growth Protein 5 (ING5) Depends on INCA1 as a Co-Factor for Its Antiproliferative Effects mā Zhang, Feng, Bäumer, Nicole, Rode, Miriam, Ji, Ping, Zhang, Tao, Berdel, Wolfgang E., Müller-Tidow, Carsten

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
19

A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis mā Bäumer, Nicole, Bäumer, Sebastian, Haak, Miriam, Koschmieder, Steffen, Schönig, Kai, Berdel, Wolfgang E., Müller-Tidow, Carsten

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
20

BCR-ABL(+) acute myeloid leukemia: are we always dealing with a high-risk disease? mā Neuendorff, Nina Rosa, Hemmati, Philipp, Arnold, Renate, Ihlow, Jana, Dörken, Bernd, Müller-Tidow, Carsten, Westermann, Jörg

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Müller‐Tidow, Carsten

Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia mā Göllner, Stefanie, Müller-Tidow, Carsten

The Indications for Allogeneic Stem Cell Transplantation in Myeloid Malignancies mā Müller, Lutz P, Müller-Tidow, Carsten

The limited contribution of DNA methylation to PML-RARα induced leukemia mā Rohde, Christian, Schoofs, Till, Müller-Tidow, Carsten

Improving consolidation therapy in acute myeloid leukemia - a tough nut to crack mā Schlenk, Richard F., Jaramillo, Sonia, Müller-Tidow, Carsten

AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting mā Wünsch, Christian, Banck, Henrik, Müller-Tidow, Carsten, Dugas, Martin

Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML mā BANCK, HENRIK, DUGAS, MARTIN, MÜLLER-TIDOW, CARSTEN, SANDMANN, SARAH

Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study mā Dugas, Martin, Lange, Matthias, Berdel, Wolfgang E, Müller-Tidow, Carsten

Characterization of the Ca(2+)-regulated Ezrin-S100P Interaction and Its Role in Tumor Cell Migration mā Austermann, Judith, Nazmi, Ali Reza, Müller-Tidow, Carsten, Gerke, Volker

The Treatment of Elderly Patients With Acute Myeloid Leukemia mā Krug, Utz, Büchner, Thomas, Berdel, Wolfgang E, Müller-Tidow, Carsten

HIS-based Kaplan-Meier plots - a single source approach for documenting and reusing routine survival information mā Breil, Bernhard, Semjonow, Axel, Müller-Tidow, Carsten, Fritz, Fleur, Dugas, Martin

Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation mā Korell, Felix, Schreck, Nicholas, Müller-Tidow, Carsten, Dreger, Peter, Luft, Thomas

Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia mā Wass, Maxi, Hitz, Friederike, Schaffrath, Judith, Müller-Tidow, Carsten, Müller, Lutz P.

DDX41-related myeloid neoplasia mā Maciejewski, Jaroslaw P., Padgett, Richard A., Brown, Anna L., Müller-Tidow, Carsten

Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment mā Marra, Alessandro, Richardsen, Gunther, Wagner, Wolfgang, Müller-Tidow, Carsten, Koch, Olaf M., Hillejan, Ludger

Hematological Malignancies in Adults With a Family Predisposition mā Bochtler, Tilmann, Haag, Georg-Martin, Schott, Sarah, Kloor, Matthias, Krämer, Alwin, Müller-Tidow, Carsten

Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity mā Schaffrath, Judith, Schmoll, Hans-Joachim, Voigt, Wieland, Müller, Lutz P., Müller-Tidow, Carsten, Mueller, Thomas

Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants mā Restle, Anja, Färber, Martin, Baumann, Cindy, Böhringer, Michael, Scheidtmann, Karl Heinz, Müller-Tidow, Carsten, Wiesmüller, Lisa

The Inhibitor of Growth Protein 5 (ING5) Depends on INCA1 as a Co-Factor for Its Antiproliferative Effects mā Zhang, Feng, Bäumer, Nicole, Rode, Miriam, Ji, Ping, Zhang, Tao, Berdel, Wolfgang E., Müller-Tidow, Carsten

A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis mā Bäumer, Nicole, Bäumer, Sebastian, Haak, Miriam, Koschmieder, Steffen, Schönig, Kai, Berdel, Wolfgang E., Müller-Tidow, Carsten

BCR-ABL(+) acute myeloid leukemia: are we always dealing with a high-risk disease? mā Neuendorff, Nina Rosa, Hemmati, Philipp, Arnold, Renate, Ihlow, Jana, Dörken, Bernd, Müller-Tidow, Carsten, Westermann, Jörg

Ngā utauta rapu: